Answers are grounded in this paper and cite their sources.
The amyloid precursor protein (APP), a key player in Alzheimers' disease (AD, is ubiquitously expressed in a large majority of neurons, including GABAergic interneurons (INTs) in the hippocampus. INT dysfunction and subsequent abnormalities in neural circuits have emerged as potential mechanisms of cognitive decline in AD. How APP expressed in selective classes of hippocampal INTs controls local neuronal activity and thereby influences brain rhythms remains unclear. We investigated the physiological function of APP in GABAergic INTs with regard to intrinsic excitability, synaptic properties and circuit activity in the hippocampal CA3 region. We selectively deleted APP, and its homolog APLP2 to prevent compensatory mechanisms, in CA3 INTs. We categorized INTs into different clusters based on morphological and electrophysiological properties, and detected only subtle differences in intrinsic excitability and dendritic complexity between control and conditional KO INTs. In contrast, the selective deletion of APP/APLP2 in CA3 INTs impaired the amplitude and kinetics of spontaneous inhibitory currents in CA3 pyramidal cells (PCs). We further performed in vivo silicon probe recordings within CA3 in head-fixed awake mice to investigate the impact of APP/APLP2 deletion on CA3 circuit activity. By analysing oscillations and the spiking activity of putative CA3 PCs and INTs we revealed alterations in the cross-frequency coupling at oscillatory frequencies in the low gamma range, as well as in the strength of connections specifically between INTs. Our work helps better understand the physiological contribution of APP to network activity and to excitatory/inhibitory balance within hippocampal circuits, which are impaired in AD.
No takes yet. Share an insight, caveat, or question.
Erhardt et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: